Full access
Professional News
Published Online: 15 July 2011

Federal Health Officials Troubled by Benzodiazepine-Abuse Data

Eve BenderAuthors Info & Affiliations
Publication: Psychiatric News
Volume 46, Number 14
https://doi.org/10.1176/pn.46.14.psychnews_46_14_13_2
Track CitationsAdd to favorites

Abstract

Nationwide data released in June show a startling nearly 300 percent increase in the number of hospital admissions for treatment of benzodiazepine abuse over the last decade.
The Substance Abuse and Mental Health Services Administration (SAMHSA) released study results in June showing that substance abuse treatment admissions related to abuse of benzodiazepines rose from 1.3 percent of all substance abuse treatment admissions in 1998 to 3.2 percent of substance abuse treatment admissions in 2008, the most recent year from which data are available.
When extrapolated to population estimates, this increase represents a jump from 22,400 benzodiazepine-related substance abuse treatment admissions in 1998 to 60,200 in 2008. Currently, there are approximately 15 drugs classified as benzodiazepines.
According to the Treatment Episode Data Set, which contains the substance abuse treatment admissions data, the vast majority of the benzodiazepine-related admissions (95 percent) included abuse of another substance as well—of these, 82.1 percent reported primary abuse of another substance with secondary use of benzodiazepines, and 12.9 percent reported primary abuse of benzodiazepines with secondary abuse of another substance.
In admissions data that reported a primary abuse of another substance, opiates were involved in 54.2 percent of the admissions. However, for adolescent admissions, marijuana accounted for the majority of primary drugs of abuse.
"The misuse of benzodiazepines along with other prescription drugs is fueling the rise of treatment admissions," said SAMHSA Administrator Pamela Hyde, J.D., in a press release announcing the findings. "Simple steps such as locking up medications and proper disposal of unused medications are easy ways people can contribute to reducing the problem."
Of admissions in which there was another drug of abuse, 86.4 percent involved earlier use of the other substance, and 13.6 percent involved use of benzodiazepines before initiation of the other substance.
The majority of benzodiazepine-related admissions were male (56 percent), non-Hispanic whites (84.8 percent), and with ages ranging from 18 to 34 (55.3 percent).
According to the report, since benzodiazepines are most often a secondary substance of abuse, "prescribing physicians may wish to screen for alcohol and other drugs of abuse and monitor patients more closely."
The report, "The TEDS Report: Substance Abuse Treatment Admissions for Abuse of Benzodiazepines" is posted at <http://oas.samhsa.gov/2k11/028/TEDS028BenzoAdmissions.htm>.

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatric News
Volume 46 • Number 14 • July 15, 2011
Pages: 13 - 21

History

Published online: 15 July 2011
Published in print: July 15, 2011

Authors

Details

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

View Options

View options

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.